Mackenzie Financial’s Organogenesis Holdings ORGO Stock Holding History

Mackenzie Financial’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-126,303	Closed	-$546K	–	1778
2025 Q1	$546K	Buy	126,303 +49,950	+65%	+$202K	﹤0.01%	1172
2024 Q4	$244K	Buy	76,353 +54,850	+255%	+$184K	﹤0.01%	1471
2024 Q3	$61.5K	Sell	21,503 -2,825	-12%	-$7.92K	﹤0.01%	1526
2024 Q2	$68.1K	Buy	24,328 +7,678	+46%	+$20.6K	﹤0.01%	1468
2024 Q1	$47.3K	Buy	16,650 +2,859	+21%	+$9.72K	﹤0.01%	1488
2023 Q4	$56.4K	Sell	13,791 -1,543	-10%	-$4.32K	﹤0.01%	1440
2023 Q3	$45.1K	Buy	15,334 +3,041	+25%	+$9.66K	﹤0.01%	1416
2023 Q2	$41.2K	Sell	12,293 -4,839	-28%	-$14.3K	﹤0.01%	1471
2023 Q1	$36.5K	Buy	+17,132	New	+$42.3K	﹤0.01%	1461

Other funds holding ORGO

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mackenzie Financial's ORGO Position: Q2 2025 in Review

Mackenzie Financial sold out of Organogenesis Holdings (ORGO) in Q2 2025, closing a stake of 126,303 shares — an estimated $546K sold.

Mackenzie Financial first reported a position in ORGO in Q1 2023 and held it in 9 quarters. The position peaked at $546K in Q1 2025. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2025.

Mackenzie Financial reported no remaining Organogenesis Holdings position as of Q2 2025 after selling out during the quarter.
Mackenzie Financial sold 126,303 Organogenesis Holdings shares in Q2 2025, an estimated $546K.
Mackenzie Financial first reported a position in Organogenesis Holdings in Q1 2023 and held it in 9 quarters.
Mackenzie Financial's Organogenesis Holdings position peaked at $546K in Q1 2025.
115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2025.

Based on Mackenzie Financial's 13F filing for Q2 2025, filed 13 Aug 2025.